ABIRATERONE ACETATE

Generic: ABIRATERONE ACETATE

Novugen Pharma (USA) LLCManufacturer
ORALRoute
ABIRATERONE ACETATEActive Substance
2022-01-05Original Approval

ABIRATERONE ACETATE is FDA application ANDA215947, sponsored by NOVUGEN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DEATH
1,523 reports
2
FATIGUE
1,149 reports
3
HOT FLUSH
741 reports
4
DISEASE PROGRESSION
608 reports
5
ASTHENIA
606 reports
6
PROSTATIC SPECIFIC ANTIGEN INCREASED
567 reports
7
DRUG INEFFECTIVE
505 reports
8
THERAPY INTERRUPTED
475 reports
9
FALL
459 reports
10
ANAEMIA
444 reports